332 related articles for article (PubMed ID: 22672900)
1. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
3. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.
Are C; Simms N; Rajput A; Brattain M
HPB (Oxford); 2010 Sep; 12(7):498-506. PubMed ID: 20815859
[TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.
Liu XQ; Rajput A; Geng L; Ongchin M; Chaudhuri A; Wang J
J Biol Chem; 2011 May; 286(18):16082-90. PubMed ID: 21454688
[TBL] [Abstract][Full Text] [Related]
5. TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.
Geng L; Chaudhuri A; Talmon G; Wisecarver JL; Wang J
PLoS One; 2013; 8(3):e59918. PubMed ID: 23536895
[TBL] [Abstract][Full Text] [Related]
6. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.
Oft M; Heider KH; Beug H
Curr Biol; 1998 Nov; 8(23):1243-52. PubMed ID: 9822576
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.
Yilmaz M; Maass D; Tiwari N; Waldmeier L; Schmidt P; Lehembre F; Christofori G
EMBO J; 2011 Sep; 30(21):4489-99. PubMed ID: 21897365
[TBL] [Abstract][Full Text] [Related]
8. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-type gastric carcinoma.
Johansson E; Komuro A; Iwata C; Hagiwara A; Fuse Y; Watanabe A; Morishita Y; Aburatani H; Funa K; Kano MR; Miyazono K
Cancer Sci; 2010 Nov; 101(11):2398-403. PubMed ID: 20718757
[TBL] [Abstract][Full Text] [Related]
9. The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer.
Ongchin M; Sharratt E; Dominguez I; Simms N; Wang J; Cheney R; LeVea C; Brattain M; Rajput A
J Surg Res; 2009 Oct; 156(2):250-6. PubMed ID: 19524264
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer.
Chowdhury S; Howell GM; Rajput A; Teggart CA; Brattain LE; Weber HR; Chowdhury A; Brattain MG
PLoS One; 2011 May; 6(5):e19335. PubMed ID: 21559296
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L
Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.
Bharathy S; Xie W; Yingling JM; Reiss M
Cancer Res; 2008 Mar; 68(6):1656-66. PubMed ID: 18339844
[TBL] [Abstract][Full Text] [Related]
14. Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.
Truty MJ; Lomberk G; Fernandez-Zapico ME; Urrutia R
J Biol Chem; 2009 Mar; 284(10):6291-300. PubMed ID: 19088080
[TBL] [Abstract][Full Text] [Related]
15. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
16. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
[TBL] [Abstract][Full Text] [Related]
17. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
18. TGFβ signaling promotes juvenile granulosa cell tumorigenesis by suppressing apoptosis.
Mansouri-Attia N; Tripurani SK; Gokul N; Piard H; Anderson ML; Eldin K; Pangas SA
Mol Endocrinol; 2014 Nov; 28(11):1887-98. PubMed ID: 25243859
[TBL] [Abstract][Full Text] [Related]
19. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
20. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
